Summary

The Senior Manager role is a strategic finance partner to the Lab Modality leaders supporting financial planning, analysis, and strategic guidance for the Lab Modalities. The Senior Manager regularly presents financial results, analyses, and strategic recommendations to the Lab Operations leadership team and plays a key role in shaping lab operations decisions by translating Modality operational performance into financial outcomes. The Senior Manager leads finance activities for Modality Lab Operations, including budgeting, forecasting, long-range planning, and investment strategy.

Job description

Position Summary

The Senior Manager role is a strategic finance partner to the Lab Modality leaders supporting financial planning, analysis, and strategic guidance for the Lab Modalities. The Senior Manager regularly presents financial results, analyses, and strategic recommendations to the Lab Operations leadership team and plays a key role in shaping lab operations decisions by translating Modality operational performance into financial outcomes. The Senior Manager leads finance activities for Modality Lab Operations, including budgeting, forecasting, long-range planning, and investment strategy.

Responsibilities

The role is highly visible to operations leadership and central to all aspects of cost management and the financial performance of our lab modality operations teams
Financial business partner to Modality leaders of the Clinical labs
Lead and report out recurring FP&A responsibilities, including the annual operating plan (budget), monthly forecast and 5-year plan for the Lab Modality Operations teams
Drive ongoing process improvement and automation to increase effectiveness and efficiency of the Lab Modalities
Create financial models for Lab Modality investments and savings, including calculation of return on investment and payback period
Review of monthly financials and KPIs related to the Lab Modalities and support function operations in accordance with company policies and US GAAP

Experience & Required Qualifications

Bachelor's degree from four-year university
Minimum 5+ years of combined experience in FP&A support
Highly proficient in Excel with a solid knowledge of data manipulation and model building; and proficient in Tableau dashboard utilization
Proactive attitude and taking initiative to engage and align with executive leaders
Proven success supporting business partners, with prior experience supporting information technology departments considered a plus
Excellent analytical and problem-solving skills

Requirements

Bachelor's degree from four-year university
Minimum 5+ years of combined experience in FP&A support
Highly proficient in Excel with data manipulation and model building
Proficient in Tableau dashboard utilization
Proactive attitude and initiative to engage and align with executive leaders
Proven success supporting business partners
Excellent analytical and problem-solving skills

Benefits

Health Insurance
401(k) Matching
Employee Stock Purchase Program
Tuition Reimbursement
Leadership Development
Paid Time Off
Wellness Courses
Employee Resource Groups

Company overview

NeoGenomics Laboratories, Inc. is a premier cancer diagnostics company specializing in comprehensive cancer genetics testing and oncology data solutions. Founded in 2002 and headquartered in Fort Myers, Florida, the company operates as a publicly traded entity on Nasdaq under the ticker NEO. NeoGenomics provides one of the most extensive oncology-focused testing menus worldwide, serving oncologists, pathologists, hospital systems, academic centers, and pharmaceutical firms with innovative diagnostic and predictive testing services. The company's testing portfolio includes cytogenetics, fluorescence in situ hybridization (FISH), flow cytometry, immunohistochemistry, anatomic pathology, and molecular genetics, with a particular emphasis on next-generation sequencing (NGS) technologies. With approximately 2,200 employees across 13 locations in the United States and Europe, NeoGenomics processes over 1.7 million cancer-related tests annually, including more than 100,000 NGS tests, serving about 4,400 medical sites and providing answers to more than 500,000 patients each year. The company maintains CAP-accredited and CLIA-certified laboratories throughout its network and has established a significant presence in cancer research through its Pharma Services Division, which supports pharmaceutical clients in clinical trials and drug development.